Morphogenis and USF Health Form Clinical Research Partnership

USF Health has partnered with UF startup and UF Innovate | Sid Martin Biotech alumn Morphogenesis, Inc., a biotechnology company developing immunotherapies for cancer patients, on a two-year contract that runs the gamut. The affiliation agreement will allow for clinical and clinical research collaborations, opportunities for students to intern for Morphogenesis, and the company will co-chair USF’s College of Pharmacy Industry Advisory Board. Through the position on the board, Morphogenesis officials could serve as guest speakers for USF’s graduate courses.